Hypoxia downregulates the expression of activating receptors involved in NK-cell-mediated target cell killing without affecting ADCC. (Q42279197)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23913266%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

title

Hypoxia downregulates the expression of activating receptors involved in NK-cell-mediated target cell killing without affecting ADCC (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23913266%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

0 references

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23913266%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Federica Raggi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23913266%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Maria Carla Bosco

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23913266%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

Mirna Balsamo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23913266%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Claudia Manzini

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23913266%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Gabriella Pietra

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23913266%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Fabiola Blengio

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23913266%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Maria Cristina Mingari

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23913266%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Luigi Varesio

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23913266%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Lorenzo Moretta

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23913266%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

language of work or name

English

0 references

publication date

5 August 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23913266%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

6 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23913266%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23913266%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23913266%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

2756-2764

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23913266%20AND%20SRC:MED&resulttype=core&format=json

Natural killer cell-directed therapies: moving from unexpected results to successful strategies

6 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

Human natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

NK cells and their receptors during viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

Homeostatic proliferation generates long-lived natural killer cells that respond against viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

Learning how to discriminate between friends and enemies, a lesson from Natural Killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

Innate or adaptive immunity? The example of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

NK cells and cancer immunosurveillance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

Activation of NK cells by ADCC responses during early HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

Enhanced in vivo growth of lymphoma tumors in the absence of the NK-activating receptor NKp46/NCR1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

Natural killer cell-based immunotherapy in cancer: current insights and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

Killer Ig–like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

Natural killer cells and solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

Altered phenotype in peripheral blood and tumor-associated NK cells from colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

Melanoma cells become resistant to NK-cell-mediated killing when exposed to NK-cell numbers compatible with NK-cell infiltration in the tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

Hypoxia--a key regulatory factor in tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

Oxygen sensing, homeostasis, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

Monocytes and dendritic cells in a hypoxic environment: Spotlights on chemotaxis and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

Hypoxia inducible factor (HIF) function in innate immunity and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

Hypoxia inhibits Moloney murine leukemia virus expression in activated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

Diametrically opposed effects of hypoxia and oxidative stress on two viral transactivators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen induction by hypoxia and hypoxia-inducible factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

HIF-1alpha is essential for myeloid cell-mediated inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

Dendritic cell reprogramming by the hypoxic environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

Hypoxia modifies the transcriptome of primary human monocytes: modulation of novel immune-related genes and identification of CC-chemokine ligand 20 as a new hypoxia-inducible gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

Hypoxia: a double-edged sword of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

Interdependence of hypoxic and innate immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

Macrophages and the hypoxic tumour microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

Molecular pathways: hypoxia response in immune cells fighting or promoting cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

Hypoxia induces T-cell apoptosis by inhibiting chemokine C receptor 7 expression: the role of adenosine receptor A(2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

Hypoxia prolongs monocyte/macrophage survival and enhanced glycolysis is associated with their maturation under aerobic conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

Natural killer cell-mediated basal and interferon-enhanced cytotoxicity against liver cancer cells is significantly impaired under in vivo oxygen conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

Primary tumor hypoxia recruits CD11b+/Ly6Cmed/Ly6G+ immune suppressor cells and compromises NK cell cytotoxicity in the premetastatic niche.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

Natural killer cells kill human melanoma cells with characteristics of cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

NK cells recognize and kill human glioblastoma cells with stem cell-like properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

Hypoxia-responsive transcription factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

Development of HIF-1 inhibitors for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

Topotecan inhibits vascular endothelial growth factor production and angiogenic activity induced by hypoxia in human neuroblastoma by targeting hypoxia-inducible factor-1alpha and -2alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

Different NK cell-activating receptors preferentially recruit Rab27a or Munc13-4 to perforin-containing granules for cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

A critical review of the role of Fc gamma receptor polymorphisms in the response to monoclonal antibodies in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

Natural killer cells: fighting viruses and much more

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

Natural killer cells are scarce in colorectal carcinoma tissue despite high levels of chemokines and cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

7 January 2021

The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

7 January 2021

Hypoxia modulates the gene expression profile of immunoregulatory receptors in human mature dendritic cells: identification of TREM-1 as a novel hypoxic marker in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

7 January 2021

Oxygen tension regulates NK cells differentiation from hematopoietic stem cells in vitro

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

7 January 2021

Anti-EGFR Antibody Cetuximab Enhances the Cytolytic Activity of Natural Killer Cells toward Osteosarcoma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343448

7 January 2021

Identifiers

DOI

10.1002/EJI.201343448

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23913266%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference